- Patent Title: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
-
Application No.: US18361545Application Date: 2023-07-28
-
Publication No.: US11884635B2Publication Date: 2024-01-30
- Inventor: Elaine Greer , Stephen Anderson , Mark Maloney , Shu Yu , Ekaterina Albert , Emily Rigsbee
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: PFIZER INC.
- Current Assignee: PFIZER INC.
- Current Assignee Address: US NY New York
- Agency: Blank Rome LLP
- The original application number of the division: US17180296 2021.02.19
- Main IPC: C07D233/88
- IPC: C07D233/88 ; A61K31/40
Abstract:
The present disclosure relates to: a) solid state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid state forms of hydrobromide salts of Compound 1 to a subject in need thereof; and d) methods for the preparation of solid state forms of Compound 1.
Public/Granted literature
Information query
